Organon & Co. (OGN) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
OGN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
OGN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 54.1% | 20.7% | 3.0% |
| 2024 | 58.0% | 23.2% | 13.5% |
| 2023 | 59.8% | 21.2% | 16.3% |
| 2022 | 62.8% | 27.6% | 14.9% |
| 2021 | 62.2% | 30.4% | 21.4% |
Download Data
Export OGN earnings history in CSV or JSON format
Free sign-in required to download data
Organon & Co. (OGN) Earnings Overview
As of May 8, 2026, Organon & Co. (OGN) reported trailing twelve-month net income of $187M, reflecting -78.4% year-over-year growth. The company earned $0.72 per diluted share over the past four quarters, with a net profit margin of 3.0%.
Looking at the long-term picture, OGN's 5-year EPS compound annual growth rate (CAGR) stands at -39.0%, signaling declining earnings. The company achieved its highest annual net income of $3.22B in fiscal 2019.
Organon & Co. maintains positive profitability with a gross margin of 54.1%, operating margin of 20.7%, and net margin of 3.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including PFE ($7.49B net income, 12.4% margin), VTRS (-$296M net income, -24.6% margin), ABBV ($4.23B net income, 6.9% margin), OGN has room to improve margins relative to the peer group. Compare OGN vs PFE →
OGN Earnings vs Peers
Earnings metrics vs comparable public companies
OGN Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $187M | -78.4% | $1.28B | $0.72 | 3.0% | 20.7% |
| 2024 | $864M | -15.5% | $1.49B | $3.33 | 13.5% | 23.2% |
| 2023 | $1.02B | +11.6% | $1.33B | $3.99 | 16.3% | 21.2% |
| 2022 | $917M | -32.1% | $1.71B | $3.59 | 14.9% | 27.6% |
| 2021 | $1.35B | -37.5% | $1.92B | $5.33 | 21.4% | 30.4% |
| 2020 | $2.16B | -32.9% | $2.85B | $8.52 | 33.1% | 43.6% |
| 2019 | $3.22B | +49.5% | $3.85B | $12.71 | 41.4% | 49.5% |
| 2018 | $2.15B | - | $2.71B | $8.51 | 22.0% | 27.7% |
See OGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOGN — Frequently Asked Questions
Quick answers to the most common questions about buying OGN stock.
Is OGN growing earnings?
OGN EPS fell to $0.72, with earnings declining -78.4%. This contrasts with the 5-year CAGR of -39.0%. TTM net income dropped to $187M.
What are OGN's profit margins?
Organon & Co. net margin is +3.0%, with operating margin at +20.7%. Below-average margins reflect competitive or cost pressures.
How consistent are OGN's earnings?
OGN earnings data spans 2018-2025. The declining earnings trend is -78.4% YoY. Historical data enables comparison across business cycles.